
Relapsed or refractory primary mediastinal B-cell lymphoma Program in Pharmaceutical Benefits Scheme (PBS) 012-20082617

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

Relapsed or refractory primary mediastinal B-cell lymphoma restriction and item codes

Do not share this attachment externally. See Freedom of Information –
Information Publication Scheme.

[] Relapsed or refractory primary mediastinal B-cell lymphoma -
pembrolizumab restriction and item codes

Contact details

PBS Complex Drugs Programs team

Forms

Relapsed or refractory primary mediastinal B-cell lymphoma -
pembrolizumab - initial authority application form (PB296)

Services Australia website links

Lymphoma - relapsed or refractory primary mediastinal B-cell lymphoma

External websites

PBS schedule for relapsed or refractory primary mediastinal B-cell
lymphoma

                                   

-   Services Australia ABN 90 794 605 008 
